|
Reduction of Lipase Activity in Product Formulation
Downstream processing of monoclonal antibodies (mAbs) has evolved to allow the specific process for a new product to be developed largely by empirical specialization of a platform process that enables removal of impurities of different kinds. A more complete characterization of impurities and the product itself would provide insights into the rational...
Published: 7/24/2024
|
Inventor(s): Kelvin Lee, Abraham Lenhoff, Kristin Valente, Nick Levy, Yatin Gokarn
Keywords(s): Drug Delivery
Category(s): Technology Classifications > Polymers, Technology Classifications > Lipase, Technology Classifications > Monoclonal, Technology Classifications > Antibodies > Receptors
|